Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Chemotherapy for Osteosarcoma
NCT00667342Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jun 2008
- Primary completion
- Aug 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in osteosarcoma (OS), Malignant Fibrous Histiocytoma of Bone (MFH), sponsored by St. Jude Children's Research Hospital. Started Jun 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
osteosarcoma (OS)Malignant Fibrous Histiocytoma of Bone (MFH)
Beyond the preview
Go deeper on NCT00667342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667342.